UB-VV400

· Nanjing IASO Biotechnology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for UB-VV400, covering 2025-09-18 to 2025-09-18. Get the full timeline:

Most recent: Clinical Trial Update: UB-VV400 in Combination With Rapamycin in Relapsed or Refractory B-cell Malignancies [Phase 1]